# BCAS2

## Overview
BCAS2, or Breast Carcinoma Amplified Sequence 2, is a gene that encodes a nuclear protein involved in pre-mRNA splicing, known as the BCAS2 pre-mRNA processing factor. This protein is a critical component of the spliceosome complex, specifically the hPrp19 complex, and plays a significant role in both constitutive and alternative splicing of mRNA. The BCAS2 protein is characterized by its coiled-coil motifs, which facilitate interactions with other splicing-related proteins, and its involvement in DNA repair processes. It is ubiquitously expressed in human tissues, underscoring its essential role in maintaining normal cellular functions. BCAS2 is also implicated in various cellular processes, including transcriptional regulation and cell cycle control, through its interactions with proteins such as the androgen receptor, estrogen receptor, and tumor suppressor p53. Its dysregulation is associated with several diseases, including neurodegenerative disorders and cancers, highlighting its clinical significance (Kuo2014BCAS2; Chen2012BCAS2).

## Structure
The BCAS2 protein, encoded by the BCAS2 gene, is a nuclear protein involved in pre-mRNA splicing. It is characterized by the presence of two coiled-coil motifs located in its C-terminal region, which are crucial for mediating protein-protein interactions (Chen2012BCAS2). These coiled-coil domains facilitate the interaction of BCAS2 with other components of the hPrp19 complex, such as CDC5L and PLRG1, which are essential for the splicing process (Chen2012BCAS2). The N-terminal domain of BCAS2 is important for its interaction with hPrp19 and plays a role in DNA repair by interacting with NBS1, a component of the MRN complex (Wang2020BCAS2).

BCAS2 is a component of the spliceosome complex and is involved in RNA processing, but specific details on its primary, secondary, tertiary, or quaternary structures are not provided in the available context. The protein is known to interact with various splicing-related proteins, including SR proteins and hnRNPs, which are trans-acting factors in alternative splicing (Chen2012BCAS2). BCAS2 may have different isoforms due to alternative splicing, impacting its function in various cellular processes (Liu2017BCAS2).

## Function
The BCAS2 gene encodes a protein that is integral to pre-mRNA splicing, a critical process in gene expression. BCAS2 is a component of the spliceosome complex, specifically the hPrp19 complex, which is essential for the assembly and activation of the spliceosome in human cells (Chen2012BCAS2). The protein enhances the efficiency of constitutive splicing and plays a role in the regulation of alternative splicing, affecting the splicing of various mRNAs, including those related to cell cycle regulation such as Cdc25C (Chen2012BCAS2).

BCAS2 interacts with several proteins involved in RNA splicing, including CDC5L, hPrp19, and PLRG1, through its C-terminal coiled-coil domains, which are crucial for its function (Chen2012BCAS2). It is also involved in the regulation of β-catenin expression, which is important for dendrite growth in neurons (Chen2022Breast). In the context of neurogenesis, BCAS2 regulates the proliferation of neural stem cells and the differentiation of immature neurons via β-catenin signaling, which is crucial for cognitive functions such as learning and memory (Chen2022Breast).

BCAS2 is active in the nucleus and is expressed ubiquitously in normal human tissues, indicating its fundamental role in maintaining normal cellular functions (Chen2012BCAS2).

## Clinical Significance
BCAS2 is implicated in several diseases due to its role in gene expression regulation and interaction with key cellular pathways. In neurodevelopment, conditional knockout of BCAS2 in mouse forebrain leads to dendritic malformation, associated with learning and memory defects. This suggests a potential link to neurodegenerative diseases such as Alzheimer's disease, where patients exhibit low BCAS2 mRNA expression and reduced hippocampal volume (Huang2016Conditional).

In prostate cancer, BCAS2 is identified as an androgen receptor (AR)-interacting protein that promotes cancer cell proliferation by enhancing AR mRNA transcription and protein stability. Its expression is significantly increased in prostate cancer tissues, particularly in high Gleason grade cases, indicating its role in disease progression. BCAS2 also suppresses the tumor-suppressor p53, further contributing to increased AR expression and cancer cell proliferation (Kuo2014BCAS2).

In breast cancer, BCAS2 acts as a coactivator of estrogen receptor alpha (ERα), enhancing its transcriptional activity and promoting carcinogenic processes. Overexpression of BCAS2 is linked to increased proliferation, clonogenicity, and migration of breast cancer cells, and is associated with tamoxifen resistance, indicating its role in breast cancer progression and endocrine resistance (SalmerónHernández2019BCAS2).

## Interactions
BCAS2 interacts with several proteins and is involved in various cellular processes. It forms a complex with the androgen receptor (AR) and HSP90, a molecular chaperone, to stabilize AR protein levels. This interaction is crucial for protecting AR from proteasomal degradation and enhancing its transcriptional activity, which is significant in prostate cancer progression (Kuo2014BCAS2). BCAS2 also interacts with NBS1, a component of the MRN complex, to enhance DNA double-strand break repair through homologous recombination and non-homologous end joining pathways. This interaction involves the N-terminal domain of BCAS2 and is essential for recruiting NBS1 to DNA damage sites (Wang2020BCAS2).

In the context of RNA splicing, BCAS2 is part of the hPrp19 complex, interacting with proteins such as CDC5L, hPrp19, and PLRG1. These interactions are facilitated by the C-terminal coiled-coil domains of BCAS2 and are crucial for pre-mRNA splicing efficiency and alternative splicing regulation (Chen2012BCAS2). BCAS2 also interacts with the tumor suppressor p53, acting as a negative regulator, and with the estrogen receptor, serving as a transcriptional cofactor (Chen2012BCAS2). These interactions highlight BCAS2's multifaceted role in cellular processes, including transcriptional regulation and cell cycle control.


## References


[1. (Huang2016Conditional) Chu-Wei Huang, Yi-Wen Chen, Yi-Rou Lin, Po-Han Chen, Meng-Hsuan Chou, Li-Jen Lee, Pei-Yu Wang, June-Tai Wu, Yeou-Ping Tsao, and Show-Li Chen. Conditional knockout of breast carcinoma amplified sequence 2 (bcas2) in mouse forebrain causes dendritic malformation via β-catenin. Scientific Reports, October 2016. URL: http://dx.doi.org/10.1038/srep34927, doi:10.1038/srep34927. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep34927)

[2. (SalmerónHernández2019BCAS2) Ángel Salmerón-Hernández, María Yamilet Noriega-Reyes, Albert Jordan, Noemi Baranda-Avila, and Elizabeth Langley. Bcas2 enhances carcinogenic effects of estrogen receptor alpha in breast cancer cells. International Journal of Molecular Sciences, 20(4):966, February 2019. URL: http://dx.doi.org/10.3390/ijms20040966, doi:10.3390/ijms20040966. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20040966)

[3. (Chen2022Breast) Hsin-Hsiung Chen, Hao-Yu Lu, Chao-Hsin Chang, Shih-Hao Lin, Chu-Wei Huang, Po-Han Wei, Yi-Wen Chen, Yi-Rou Lin, Hsien-Sung Huang, Pei-Yu Wang, Yeou-Ping Tsao, and Show-Li Chen. Breast carcinoma-amplified sequence 2 regulates adult neurogenesis via β-catenin. Stem Cell Research &amp; Therapy, April 2022. URL: http://dx.doi.org/10.1186/s13287-022-02837-9, doi:10.1186/s13287-022-02837-9. This article has 4 citations.](https://doi.org/10.1186/s13287-022-02837-9)

[4. (Kuo2014BCAS2) P-C Kuo, C-W Huang, C-I Lee, H-W Chang, S-W Hsieh, Y-P Chung, M-S Lee, C-S Huang, L-P Tsao, Y-P Tsao, and S-L Chen. Bcas2 promotes prostate cancer cells proliferation by enhancing ar mrna transcription and protein stability. British Journal of Cancer, 112(2):391–402, December 2014. URL: http://dx.doi.org/10.1038/bjc.2014.603, doi:10.1038/bjc.2014.603. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/bjc.2014.603)

[5. (Liu2017BCAS2) Wenbo Liu, Fengchao Wang, Qianhua Xu, Junchao Shi, Xiaoxin Zhang, Xukun Lu, Zhen-Ao Zhao, Zheng Gao, Huaixiao Ma, Enkui Duan, Fei Gao, Shaorong Gao, Zhaohong Yi, and Lei Li. Bcas2 is involved in alternative mrna splicing in spermatogonia and the transition to meiosis. Nature Communications, January 2017. URL: http://dx.doi.org/10.1038/ncomms14182, doi:10.1038/ncomms14182. This article has 58 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms14182)

[6. (Wang2020BCAS2) Li-Po Wang, Tzu-Yu Chen, Chun-Kai Kang, Hsiang-Po Huang, and Show-Li Chen. Bcas2, a protein enriched in advanced prostate cancer, interacts with nbs1 to enhance dna double-strand break repair. British Journal of Cancer, 123(12):1796–1807, September 2020. URL: http://dx.doi.org/10.1038/s41416-020-01086-y, doi:10.1038/s41416-020-01086-y. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41416-020-01086-y)

[7. (Chen2012BCAS2) Po-Han Chen, Chia-I Lee, Yu-Tzu Weng, Woan-Yuh Tarn, Yeou-Ping Tsao, Ping-Chang Kuo, Pang-Hung Hsu, Chu-Wei Huang, Chiun-Sheng Huang, Hsiu-Hsiang Lee, June-Tai Wu, and Show-Li Chen. Bcas2 is essential for drosophila viability and functions in pre-mrna splicing. RNA, 19(2):208–218, December 2012. URL: http://dx.doi.org/10.1261/rna.034835.112, doi:10.1261/rna.034835.112. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1261/rna.034835.112)